 |
市场调查报告书
商品编码
1568886
医疗科技业研发投入分析R&D Investment Analysis of the Medtech Sector |
||||||
人工智慧与医疗设备小型化的融合将推动变革性成长
在 COVID-19 大流行之前，医疗技术 (medtech) 在研发方面进行了大量投资。然而，儘管疫情后投资趋势有所下降，但正逐渐恢復动能。顶级医疗技术公司将其总收入的约 7% 至 8% 投资于新产品的研发和现有产品的增强。医疗技术研发投资的主要来源是企业预算、创业投资和私募股权公司、政府津贴、公共资金以及伙伴关係和合作。
Frost & Sullivan 对医疗技术研发投资的研究包括成长动力和阻碍因素、併购交易分析（包括 2022 年顶级交易）、区域分析、影响医疗技术研发投资的外部因素分析、未来 10 年的预测和关键。了公司的成长机会。
本研究重点关注循环系统和神经病学这两个主要治疗领域，并重点介绍与主要研发投资和主要併购活动（包括近期的）相关的关键技术趋势。
循环系统的投资主要集中在基于人工智慧的先进诊断工具、植入小型化、远端患者监护和微创手术技术。
神经学领域的投资主要集中在神经调节设备、植入和穿戴式监测设备的创新。
分析中回答的关键问题
医疗技术研发投入的主要成长要素与阻碍因素有哪些？循环系统和神经科医疗技术研发投入的主要技术趋势是什么？循环系统和神经病学的主要研发投资活动有哪些？循环系统和神经病学领域的主要併购活动有哪些？从2022年5大併购交易分析可以看出什么？从医疗技术研发投入的区域分析可以看出什么？哪些外在因素影响医疗技术研发投入？您对未来10年医疗技术研发投入有何预测？市场参与企业的主要成长机会是什么？
目录
战略问题
- 为什么成长如此困难？
- The Strategic Imperative 8（TM）
- 三大策略重点对医疗科技产业研发投入的影响
- 成长机会是Growth Pipeline Engine（TM）
- 调查方法
成长机会分析
- 分析范围
- 医疗技术研发投入及主要目标
- 医疗技术研发投入来源
- 2023年四大医疗设备生产企业研发费用状况
- 按治疗领域细分
成长要素
- 生长促进因子
- 成长抑制因素
細項分析：循环系统领域
- 医疗技术：研发投入主要技术趋势：循环系统领域
- 医疗科技：循环系统领域研发投入（2024年）
- 医疗科技：循环系统领域研发投入（2023年）
- 医疗科技：循环系统领域主要併购活动：循环系统领域（2024年）
片段分析：神经区域
- 医疗技术：研发投资主要技术趋势：神经病学
- 医疗技术：神经病学研发投资（2024）
- 医疗技术：神经病学研发投资（2023）
- 医疗技术：神经病学领域的主要併购活动
市场分析
- 医疗科技领域併购交易金额
- 2022 年 5 大併购交易
- 区域分析
- 外在因素对医疗技术研发投入的影响
- 未来10年的预测
医疗技术研发领域充满成长机会
- 成长机会一：新兴国家的研发投入
- 成长机会二：微创产品与AI融合
- 成长机会 3：持续病患监测解决方案
附录
- 技术成熟度等级 (TRL)：解释
下一步
- 成长机会的好处和影响
- 下一步
- 免责声明
Artificial Intelligence Integration and Medical Devices Miniaturization to Drive Transformational Growth
Before the COVID-19 pandemic, medical technology (medtech) registered significant investment in R&D. However, the investment trend declined post-pandemic but is gradually picking up momentum. Top medtech companies invest about 7% to 8% of their total revenues toward the R&D of novel products or to enhance existing products. The key sources for medtech R&D investments are corporate budgets, venture capital and private equity firms, government grants, public funding, and partnerships and collaborations.
This Frost & Sullivan research on medtech R&D investment covers growth drivers and restraints; analysis of M&A deals, including the top deals in 2022; regional analysis; analysis of external factors impacting medtech R&D investment; predictions for the next decade; and key growth opportunities for companies.
The study focuses on cardiology and neurology as two top therapy areas covering key technological trends involved with significant R&D investments, including recent ones, and major M&A activities.
Investments in cardiology are focused on advanced AI-based diagnostic tools, implant miniaturization, remote patient monitoring, and minimally invasive techniques for surgery.
Investments in neurology are focused on innovation in neuromodulation devices, implants, and wearable monitoring devices.
Key Questions Answered in the Analysis:
What are the key growth drivers and restraints for medtech R&D investment? What are the key technological trends for medtech R&D investment for cardiology and neurology? What are the key R&D investment activities in cardiology and neurology? What are the key M&A activities in cardiology and neurology? What does the analysis of the top 5 M&A deals in 2022 reveal? What does the regional analysis for medtech R&D investment reveal? What external factors impact medtech R&D investments? What are the predictions for medtech R&D investment during the next decade? What are the key growth opportunities for market participants?
Table of Contents
Strategic Imperatives
- Why Is It Increasingly Difficult to Grow?
- The Strategic Imperative 8™
- The Impact of the Top 3 Strategic Imperatives on R&D Investment in the Medtech Industry
- Growth Opportunities Fuel the Growth Pipeline Engine™
- Research Methodology
Growth Opportunity Analysis
- Scope of Analysis
- Medtech R&D Investments and Key Goals
- Sources of Medtech R&D Investment
- R&D Spending by Top 4 Medical Devices Companies in 2023
- Segmentation by Therapy Areas*
Growth Generator
- Growth Drivers
- Growth Restraints
Segment Analysis: Cardiology
- Major Technological Trends in R&D Investments for Medtech: Cardiology
- Key R&D Investments in Medtech: Cardiology (2024)
- Key R&D Investments in Medtech: Cardiology (2023)
- Key M&A Activities in Medtech: Cardiology (2024)
Segment Analysis: Neurology
- Major Technological Trends in R&D Investments for Medtech: Neurology
- Key R&D Investments in Medtech: Neurology (2024)
- Key R&D Investments in Medtech: Neurology (2023)
- Key M&A Activities in Medtech: Neurology
Market Analysis
- Value of M&A Deals in Medical Technology
- Top 5 M&A Deals of 2022
- Regional Analysis
- Impact of External Factors on Medtech R&D Investments
- Predictions for the Next Decade
Growth Opportunity Universe in Medtech R&D
- Growth Opportunity 1: R&D Investment in Developing Countries
- Growth Opportunity 2: Minimally Invasive Products and AI Integration
- Growth Opportunity 3: Continuous Patient Monitoring Solutions
Appendix
- Technology Readiness Levels (TRL): Explanation
Next Steps
- Benefits and Impacts of Growth Opportunities
- Next Steps
- Legal Disclaimer
